AnHui HaiKang Pharmaceutical CO.,LTD

(1) for the treatment of chronic, accelerated, or blastic phases of Philadelphia chromosome-positive chronic myeloid leukemia (Ph + CML). The company is located in:

(2) Adult patients for treating malignant gastrointestinal stromal tumors (GISTs) with unresectable and / or metastatic disease for the treatment of myelodysplastic syndromes / myeloproliferative disorders (MDS / MPD) with platelet-derived growth Adult patients with factor receptor (PDGFR) gene rearrangement;

English name: Imatinib mesylate

CAS number: 220127-57-1

Molecular formula: C30H35N7O4S

Molecular weight: 589.71

English name :GLIVEC;GLEEVEC;IMATINIB METHANESULFONATE;CGP-57148B;4-[(4-methylpiperazin-1-yl)methyl]-n-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate;4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate;STI-571;IMATINIB BASE(IMA-3)